Business Briefing: Biogen Idec Alzheimer’s Drug to Receive Late-Stage Study
Tuesday, December 2, 2014 - 21:30
in Health & Medicine
The company said the drug reduced levels of plaque in the brain and significantly improved cognition in a small early-stage study.